Tagged: timelines

Enrollment as a Learning Problem

The Tufts Center for the Study of Drug Development’s January/February 2013 Impact Report has stirred comment and criticism. Paul Ivsin of Placebo Control dismisses the significance of learning that 48% of sites miss their enrollment targets; Ed Silverman at Pharmalot does the reverse.  The biggest takeaway from my perspective is this: “Study timelines typically extended… Read more »